Abstract
In a randomised, placebo controlled, double blind study inosine pranobex was assessed as a possible second line drug in rheumatoid arthritis. Twenty four patients received inosine pranobex (3 g/day) and 26 patients received placebo for up to 24 weeks. Morning stiffness, articular index, grip strength, pain score, erythrocyte sedimentation rate, C reactive protein, IgG, IgM, and serum urate were assessed at weeks 0, 12, and 24. Baseline characteristics were similar except for a significantly higher C reactive protein in the placebo group. No significant improvement occurred in any variable: (a) when comparing week 0 with week 12 or week 24 for either group, (b) comparing active drug with placebo at week 12 or 24, or (c) taking all 50 patients as one group. Withdrawal from the study for lack of response or side effects was similar in both groups. Serum urate increased transiently but significantly with inosine pranobex (a recognised side effect). It is concluded that inosine pranobex has no second line activity in rheumatoid arthritis. Further, 50 patients effectively given placebo showed no spontaneous improvement in their disease activity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Becker H., Helmke K. Inosiplex enhances the growth of Epstein-Barr nuclear antigen-positive B-cells from patients with rheumatoid arthritis and infectious mononucleosis. Int J Immunopharmacol. 1988;10(4):439–443. doi: 10.1016/0192-0561(88)90131-2. [DOI] [PubMed] [Google Scholar]
- Becker H., Loers E., Helmke K., Federlin K. Therapie rheumatischer Erkrankungen mit Inosiplex. Immun Infekt. 1986 May;14(3):93–99. [PubMed] [Google Scholar]
- Galli M., Lazzarin A., Moroni M., Zanussi C. Inosiplex in recurrent herpes simplex infections. Lancet. 1982 Aug 7;2(8293):331–332. doi: 10.1016/s0140-6736(82)90300-2. [DOI] [PubMed] [Google Scholar]
- Nakamura T., Miyasaka N., Pope R. M., Talal N., Russell I. J. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases. Clin Exp Immunol. 1983 Apr;52(1):67–74. [PMC free article] [PubMed] [Google Scholar]
- Wybran J., Famaey J. P., Appelboom T. Inosiplex: a novel treatment in rheumatoid arthritis? J Rheumatol. 1981 Jul-Aug;8(4):643–646. [PubMed] [Google Scholar]